In the News November 21, 2018

Law360 | FDA Finally Hitting Sweet Spot with Off-Label Oversight

Marc Scheineson comments on off-label oversight by the U.S. Food and Drug Administration.
Media Contact
Nicholas Clarke
Senior Communications Manager
Phone: 212.210.1222

This website uses cookies to improve functionality and performance. For more information, see our Privacy Statement. Additional details for California consumers can be found here.